Effects of a meal replacement system alone or in combination with phentermine on weight loss and food cravings

Obesity

Volumn 24, Issue 11, 2016, Pages 2344-2350

  Moldovan, Christina P ^a   Weldon, Abby J ^a   Daher, Noha S ^a   Schneider, Louise E ^a   Bellinger, Denise L ^b   Berk, Lee S ^a   Hermé, Alyson C ^a   Aréchiga, Adam L ^a   Davis, Willie L ^a   Peters, Warren R ^b  

^a LOMA LINDA UNIVERSITY   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENTERMINE; PLACEBO; ANOREXIGENIC AGENT;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIET THERAPY; DOUBLE BLIND PROCEDURE; FAT CRAVING; FEMALE; FOOD CRAVING; HEALTH PROMOTION; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEAL REPLACEMENT PROGRAM; OBESITY; RANDOMIZED CONTROLLED TRIAL; SWEET CRAVING; TREATMENT DURATION; WEIGHT REDUCTION; CRAVING; DRUG EFFECTS; LIFESTYLE; MEAL; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROCEDURES; WEIGHT LOSS PROGRAM;

ADULT; APPETITE DEPRESSANTS; COMBINED MODALITY THERAPY; CRAVING; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIFE STYLE; MALE; MEALS; MIDDLE AGED; OBESITY; PHENTERMINE; WEIGHT LOSS; WEIGHT REDUCTION PROGRAMS;

EID: 84993661791     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21649     Document Type: Article

References (33)

1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014;311:806–814.
2. Haboush A, Phebus T, Tanata Ashby D, Zaikina-Montgomery H, Kindig K. Still unhealthy 2009: building community research to identify risk factors and health outcomes in childhood obesity. J Commun Health 2011;36:111–120.
3. Early JL, Apovian CM, Aronne LJ, et al. Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients. Obesity (Silver Spring) 2007;15:1464–1472.
4. Frank A. The long-term management of obesity with continuing pharmacotherapy. Obes Res 2004;12:1821–1827.
5. Gudzune KA, Doshi RS, Mehta AK, et al. Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med 2015;162:501–512.
6. Hendricks EJ, Greenway FL, Westman EC, Gupta AK. Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity. Obesity (Silver Spring) 2011;19:2351–2360.
7. Hendricks EJ, Rothman RB, Greenway FL. How physician obesity specialists use drugs to treat obesity. Obesity (Silver Spring) 2009;17:1730–1735.
8. Heymsfield SB, van Mierlo CA, van der Knaap HC, Heo M, Frier HI. Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Int J Obes Relat Metab Disord 2003;27:537–549.
9. Davis LM, Coleman C, Kiel J, et al. Efficacy of a meal replacement diet plan compared with a food-based diet plan after a period of weight loss and weight maintenance: a randomized controlled trial. Nutr J 2010;9:11.
10. Shikany JM, Thomas AS, Beasley TM, Lewis CE, Allison DB. Randomized controlled trial of the Medifast 5 & 1 Plan for weight loss. Int J Obes (Lond) 2013;37:1571–1578.
11. Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2015;100:342–362.
12. Fujioka K. Current and emerging medications for overweight or obesity in people with comorbidities. Diabetes Obes Metab 2015;17:1021–1032.
13. Haddock CK, Poston WS, Dill PL, Foreyt JP, Ericsson M. Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials. Int J Obes Relat Metab Disord 2002;26:262–273.
14. Li Z, Maglione M, Tu W, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med 2005;142:532–546.
15. Hall DM, Most MM. Dietary adherence in well-controlled feeding studies. J Am Diet Assoc 2005;105:1285–1288.
16. Swinburn B, Egger G. The runaway weight gain train: too many accelerators, not enough brakes. BMJ 2004;329:736–739.
17. Weingarten HP, Elston D. The phenomenology of food cravings. Appetite 1990;15:231–246.
18. Lafay L, Thomas F, Mennen L, et al. Gender differences in the relation between food cravings and mood in an adult community: results from the fleurbaix laventie Ville Sante study. Int J Eat Disord 2001;29:195–204.
19. Abilés V, Rodríguez-Ruiz S, Abilés J, et al. Psychological characteristics of morbidly obese candidates for bariatric surgery. Obes Surg 2010;20:161–167.
20. Franken IH, Muris P. Individual differences in reward sensitivity are related to food craving and relative body weight in healthy women. Appetite 2005;45:198–201.
21. Pelchat ML, Schaefer S. Dietary monotony and food cravings in young and elderly adults. Physiol Behav 2000;68:353–359.
22. Martin CK, O'Neil PM, Pawlow L. Changes in food cravings during low-calorie and very-low-calorie diets. Obesity (Silver Spring) 2006;14:115–121.
23. Martin CK, Rosenbaum D, Han H, et al. Change in food cravings, food preferences, and appetite during a low-carbohydrate and low-fat diet. Obesity (Silver Spring) 2011;19:1963–1970.
24. White MA, Whisenhunt BL, Williamson DA, Greenway FL, Netemeyer RG. Development and validation of the food-craving inventory. Obes Res 2002;10:107–114.
25. Nijs IM, Franken IH, Muris P. The modified Trait and State Food-Cravings Questionnaires: development and validation of a general index of food craving. Appetite 2007;49:38–46.
26. Haddock CK, Poston WS, Foreyt JP, DiBartolomeo JJ, Warner PO. Effectiveness of Medifast supplements combined with obesity pharmacotherapy: a clinical program evaluation. Eat Weight Disord 2008;13:95–101.
27. Thomas EA, McNair B, Bechtell JL, Ferland A, Cornier MA, Eckel RH. Greater hunger and less restraint predict weight loss success with phentermine treatment. Obesity (Silver Spring) 2016;24:37–43.
28. Karelis AD, Chamberland G, Aubertin-Leheudre M, Duval C, Ecological Mobility in Aging and Parkinson (EMAP) Group. Validation of a portable bioelectrical impedance analyzer for the assessment of body composition. Appl Physiol Nutr Metab 2013;38:27–32.
29. Coleman CD, Kiel JR, Mitola AH, Langford JS, Davis KN, Arterburn LM. Effectiveness of a Medifast meal replacement program on weight, body composition and cardiometabolic risk factors in overweight and obese adults: a multicenter systematic retrospective chart review study. Nutr J 2015;14:77.
30. Thomas PR, ed. Weighing the Options: Criteria for Evaluating Weight-Management Programs. Washington, DC: National Academies Press; 1995.
31. Stiegler P, Cunliffe A. The role of diet and exercise for the maintenance of fat-free mass and resting metabolic rate during weight loss. Sports Med 2006;36:239–262.
32. Treyzon L, Chen S, Hong K, et al. A controlled trial of protein enrichment of meal replacements for weight reduction with retention of lean body mass. Nutr J 2008;7:23.
33. Chao A, Grilo CM, White MA, Sinha R. Food cravings, food intake, and weight status in a community-based sample. Eat Behav 2014;15:478–482.